Impact of Implementing a Pharmacy-Driven Intervention Bundle on Hospital Readmission Rates for Patients With Heart Failure.

This article evaluates the impact of a pharmacy-driven intervention bundle on 30-day hospital readmission rates for patients with heart failure (HF). Conducted as a single-center pre-post interventional study, the intervention included HF-directed medication reconciliation, discharge counseling, enrollment in a medication supply program (Meds2Beds), and a 72-hour postdischarge follow-up phone call by pharmacists. While the intervention group showed a nonsignificant reduction in 30-day all-cause readmissions compared to the control group (18.5% vs. 21.2%), it significantly increased the proportion of patients discharged on guideline-directed medical therapy (GDMT), particularly sodium-glucose cotransporter-2 inhibitors (SGLT2i). The study highlights the potential role of pharmacists in optimizing HF care transitions and medication management, though limitations such as staffing constraints and baseline group differences affected the ability to demonstrate statistically significant reductions in readmission rates.